Suppr超能文献

相似文献

1
Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.
J Am Soc Nephrol. 2010 Mar;21(3):507-19. doi: 10.1681/ASN.2008121259. Epub 2010 Feb 11.
2
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
Clin J Am Soc Nephrol. 2012 Sep;7(9):1394-400. doi: 10.2215/CJN.02170312. Epub 2012 Jul 5.
3
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Clin J Am Soc Nephrol. 2020 Dec 7;15(12):1762-1776. doi: 10.2215/CJN.02500220. Epub 2020 Nov 30.
4
Idiopathic membranous nephropathy: an autoimmune disease.
Semin Nephrol. 2011 Jul;31(4):333-40. doi: 10.1016/j.semnephrol.2011.06.004.
6
Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease.
EBioMedicine. 2015 Mar 6;2(5):456-66. doi: 10.1016/j.ebiom.2015.03.003. eCollection 2015 May.
7
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.
Kidney Int. 2020 Jan;97(1):163-174. doi: 10.1016/j.kint.2019.09.014. Epub 2019 Oct 7.
10
[Secondary membranous nephropathy].
Nihon Jinzo Gakkai Shi. 2011;53(5):697-702.

引用本文的文献

1
Oxidative Stress and Nutritional Antioxidants in Renal Diseases: A Narrative Review.
Antioxidants (Basel). 2025 Jun 20;14(7):757. doi: 10.3390/antiox14070757.
2
Benzo[b]fluoranthene is involved in idiopathic membranous nephropathy by inducing podocyte injury.
J Transl Int Med. 2025 May 9;13(2):118-127. doi: 10.1515/jtim-2025-0022. eCollection 2025 Apr.
3
Technology Innovation for Discovering Renal Autoantibodies in Autoimmune Conditions.
Int J Mol Sci. 2024 Nov 25;25(23):12659. doi: 10.3390/ijms252312659.
4
Single-dose telitacicept therapy for refractory idiopathic membranous nephropathy: A case series.
Clin Case Rep. 2024 Nov 6;12(11):e9553. doi: 10.1002/ccr3.9553. eCollection 2024 Nov.
5
THSD7A-associated membranous nephropathy involves both complement-mediated and autonomous podocyte injury.
Front Pharmacol. 2024 Jul 17;15:1430451. doi: 10.3389/fphar.2024.1430451. eCollection 2024.
6
Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond.
Clin Kidney J. 2023 Dec 11;17(1):sfad228. doi: 10.1093/ckj/sfad228. eCollection 2024 Jan.
7
Mechanisms Limiting Renal Tissue Protection and Repair in Glomerulonephritis.
Int J Mol Sci. 2023 May 5;24(9):8318. doi: 10.3390/ijms24098318.
9
An update on autoantibodies in systemic lupus erythematosus.
Curr Opin Rheumatol. 2023 Mar 1;35(2):61-67. doi: 10.1097/BOR.0000000000000922. Epub 2022 Dec 22.
10
miR-122-5p Regulates Renal Fibrosis In Vivo.
Int J Mol Sci. 2022 Dec 6;23(23):15423. doi: 10.3390/ijms232315423.

本文引用的文献

2
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
3
Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats.
Mol Cell Biochem. 2008 Oct;317(1-2):43-50. doi: 10.1007/s11010-008-9803-8. Epub 2008 Jun 26.
4
Chronic hypoxia aggravates renal injury via suppression of Cu/Zn-SOD: a proteomic analysis.
Am J Physiol Renal Physiol. 2008 Jan;294(1):F62-72. doi: 10.1152/ajprenal.00113.2007. Epub 2007 Oct 24.
5
Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.
Semin Immunopathol. 2007 Nov;29(4):445-58. doi: 10.1007/s00281-007-0091-2. Epub 2007 Sep 26.
7
Developmental expression and function of aldehyde reductase in proximal tubules of the kidney.
Am J Physiol Renal Physiol. 2005 Jul;289(1):F200-7. doi: 10.1152/ajprenal.00411.2004. Epub 2005 Mar 15.
8
Aldose reductase-catalyzed reduction of aldehyde phospholipids.
J Biol Chem. 2004 Dec 17;279(51):53395-406. doi: 10.1074/jbc.M403416200. Epub 2004 Oct 1.
10
Pathomechanisms and molecular basis of membranous glomerulopathy.
Lancet. 2004;364(9441):1194-6. doi: 10.1016/S0140-6736(04)17154-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验